ClinicalTrials.gg
TerminatedNCT01671033Updated Aug 23, 2012

Treatment of Panic Disorder Via Internet With a Wireless Temperature Biofeedback Ring

An interventional study of Biofeedback and Muscle Relaxation in Panic Disorder, sponsored by Chimei Medical Center. Terminated at 1 site in Taiwan. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2012-08-23.

Sponsored by Chimei Medical Center · Not applicable, Interventional, and Treatment

Why this study was terminated
The drop-out rate was too high.
Phase
Not applicable
Study type
Interventional
Enrollment
9
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

From the scarce literature it showed that computer/internet-aided cognitive behavior therapy (CBT) was superior to waitlist and placebo assignment across outcome measures, and the effects of computer/internet-aided CBT were equal to therapist-delivered treatment across anxiety disorders. The aim of this study is to evidence the effectiveness of internet-based relaxation with biofeedback treatment for panic disorder.

Read the detailed description

All participants had access to a computer with an internet connection and received the treatment via internet.

02

Conditions studied

  • Panic Disorder

Browse trials for

Keywords

  • Panic disorder
  • cognitive behavior therapy
  • Internet
03

In context

Panic Disorder

256 studies on the registry are indexed under Panic Disorder; 35 are open to participants now.

This study's enrollment of 9 is below the median of 78 across 201 interventional studies indexed under Panic Disorder.

Browse Panic Disorder studies →

Lead sponsor

Chimei Medical Center is the lead sponsor of 27 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. The participant must fulfill DSM-IV criteria for panic disorder.
  2. The participant must be between 20 and 60 years of age.
  3. The participant must have the Panic Disorder Severity Scale(PDSS) score ≧8.
  4. If the participant is taking prescribed drugs for panic disorder, a) the dosage have to be constant for 6 weeks before starting treatment, and b) the participant have to agree to keep the dosage constant for 2 months after starting treatment.
  5. If the participant was already in therapy, the contact must have lasted at least 3 months and not be based on cognitive behavior therapy.
  6. All participants have access to a computer with an Internet connection.

Exclusion criteria

Exclusion Criteria:

  1. The participant suffers from any other psychiatric disorder in immediate need of treatment.
  2. The participant fulfills DSM-IV criteria for major depression.
  3. The participant has epilepsy, kidney problems, strokes, organic brain syndrome, emphysema, heart disorders, or chronic hypertension.
  4. The participant has alcoholism or substance dependence.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
9 participants (actual)

Study arms

  • Experimental
    Muscle Relaxation

    The patients of this arm practice on-line muscle relaxation every day.They complete the Brief Symptom Rating Scale(BSRS), Family APGAR(APGAR), the Chinese-version of the Medical Outcomes Study 36-Item Short Form Health Survey(SF-36), and the panic diary via internet browser. The Panic Disorder Severity Scale(PDSS)and Clinical Global Impression (CGI) were performed by well-trained clinicians.

    Behavioral: Muscle Relaxation

  • Experimental
    Muscle Relaxation with Biofeedback

    The patients of this arm practice on-line muscle relaxation with finger temperature biofeedback every day. They complete the Brief Symptom Rating Scale(BSRS), Family APGAR(APGAR), the Chinese-version of the Medical Outcomes Study 36-Item Short Form Health Survey(SF-36), and the panic diary via internet browser. The Panic Disorder Severity Scale(PDSS)and Clinical Global Impression (CGI) were performed by well-trained clinicians.

    Behavioral: Biofeedback · Behavioral: Muscle Relaxation

  • No intervention
    Waiting-List

    The patients of this arm waited for four weeks. They complete the Brief Symptom Rating Scale(BSRS), Family APGAR (APGAR), the Chinese-version of the Medical Outcomes Study 36-Item Short Form Health Survey(SF-36), and the panic diary via internet browser. The Panic Disorder Severity Scale(PDSS)and Impressions-Improvement(CGI) were performed by well-trained clinicians.

Interventions

  • BehavioralBiofeedback

    Patients with panic disorder practice muscle relaxation with temperature biofeedback monitor, and send the temperature data to server via internet every day. Therapist gives comments and suggestions on line. Patients also have to complete some self-rating scales on browser every day or every week.

    Also known as: finger temperature biofeedback

  • BehavioralMuscle Relaxation

    Patients with panic disorder practice muscle relaxation via internet every day. Therapist gives comments and suggestions on line. Patients also have to complete some self-rating scales on browser every day or every week.

06

What researchers measure

Primary outcomes

  1. Score Change of The Panic Disorder Severity Scale(PDSS)

    Time frame: Baseline / Week 4/ Week 8/ Week12/ Week 16

Secondary outcomes

  1. Score Change of relaxation-rating

    Time frame: Baseline / Week 4/ Week 8/ Week 12/ Week 16

07

Study locations

1 site
  • Chimei Medical Center
    Tainan, 70246, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 23, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01671033
Lead sponsor
Chimei Medical Center
Collaborators
National Cheng Kung University
Responsible party
Fong-Lin Jang (M.D., Chimei Medical Center) — Principal investigator
First posted
Aug 23, 2012
Start date
Feb 2010
Primary completion
Dec 2010
Completion
Jan 2011
Last update
Aug 23, 2012

Study contacts

Fong-Lin Jang, M.D.
study director · Chimei Medical Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Apr 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion